( March 23, 2026, 2:22 PM EDT) -- NEW ORLEANS — A Louisiana federal judge granted an unopposed motion for summary judgment filed by generic manufacturers of a chemotherapy drug that allegedly caused eye injuries after agreeing that a previous ruling granting summary judgment to other generic manufacturers applied “with equal force to them” and that they could not unilaterally change their labels because they lacked any “newly acquired information” about the danger of the drugs, making claims against them preempted by federal law....